Top

Intent to Announce for RPP 18-11 of MCDC OTA

Active

W15QKN18Z03DQFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The announcement serves as an advance notification of the Government’s intent to issue a Request for Prototype Proposals (RPP 18-11) under the Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA). This announcement does not constitute a solicitation for project awards but informs industry members and consortium participants about upcoming opportunities related to Medical Countermeasure Systems research and development. The Government previously established the MCDC OTA in April 2016 to facilitate prototype projects focused on medical countermeasures, and the forthcoming solicitation will target the development of an FDA-approved smallpox medical countermeasure for post-exposure prophylaxis to be used alongside vaccination. The anticipated project will invite white papers and full proposals via solicitation number W15QKN-16-9-1002, with awards expected to be made exclusively to MCDC members. Importantly, a Prototype OTA awarded as a result of the solicitation may lead to a follow-on production contract without additional competitive procedures, contingent upon successful project completion, pursuant to federal acquisition regulations. The Department of Defense office overseeing this initiative is located at Picatinny Arsenal, NJ, with Peter W. Gerhard serving as the Agreements Officer contact. This step signifies the Government’s strategic approach to expediting medical countermeasure development through streamlined acquisition mechanisms within the defense and medical research communities.

General Info

Government to issue prototype proposals for FDA-approved smallpox countermeasure via MCDC OTA.

Agency

Department Of Defense → W6QK Acc-Pica

NAICS

541990 - All Other Professional, Scientific, and Technical Services

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedAug 6

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Pica

Contacts1 person available

OfficePICATINNY ARSENAL, NJ, 07806-5000, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Pica

Office AddressPICATINNY ARSENAL, NJ, 07806-5000, USA

Contacts

Peter W. GerhardAgreements Officer

contact@example.gov

+1 (555) 000-0000

Full Description

This is not a Request for Prototype Proposals, but for planning purposes only. A project award will not be awarded from this announcement. The Government intends to announce one Request for Prototype Proposals (RPP 18-11) for execution of a project award(s) in support of Medical Countermeasure Systems Research and Development related to specified project requirements. The purpose of this announcement is to provide members of the Medical CBRN Defense Consortium, and industry in general, advanced notification of Government intent. On 08 April 2016, the Government entered into an Other Transaction Agreement (OTA) with one (1) consortium, the Medical CBRN Defense Consortium (MCDC), in support of Medical Countermeasure Systems related research and development prototype projects. It is the intent of the Government to make project award(s) to member(s) of the MCDC as a result of member project proposals submitted via the Request for Prototype Proposals process. RPP 18-11 The Government anticipates one (1) project for white papers and full proposals to be solicited via W15QKN-16-9-1002 - consisting of the following: 1. Development of an FDA-Approved Smallpox Medical Countermeasure for a Post-Exposure Prophylaxis Indication in Conjunction with Vaccination. Please note that any Prototype Other Transaction Agreement awarded in response to the anticipated RPP (solicitation) will include the following statement relative to the potential for follow-on production: "In accordance with 10.U.S.C. 2371b(f), and upon a determination that the prototype project for this transaction has been successfully completed, this competitively awarded prototype OTA may result in the award of a follow-on production contract or transaction without the use of competitive procedures."